172 related articles for article (PubMed ID: 26362073)
1. Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed.
Necchi A; Giannatempo P; Lo Vullo S; Raggi D; Nicolai N; Colecchia M; Perrone F; Mariani L; Salvioni R
Clin Genitourin Cancer; 2016 Jun; 14(3):231-6. PubMed ID: 26362073
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
3. First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study.
Necchi A; Lo Vullo S; Perrone F; Raggi D; Giannatempo P; Calareso G; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Togliardi E; Colecchia M; Busico A; Gloghini A; Testi A; Mariani L; Salvioni R
BJU Int; 2018 Mar; 121(3):348-356. PubMed ID: 28921872
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.
Zhang S; Zhu Y; Ye D
Oncotarget; 2015 Oct; 6(31):32212-9. PubMed ID: 26311739
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma.
Pond GR; Milowsky MI; Kolinsky MP; Eigl BJ; Necchi A; Harshman LC; Di Lorenzo G; Dorff TB; Lee RJ; Sonpavde G
Clin Genitourin Cancer; 2014 Dec; 12(6):440-6. PubMed ID: 24787971
[TBL] [Abstract][Full Text] [Related]
6. Treatment of unresectable squamous cell carcinoma of the skin with epidermal growth factor receptor antibodies--a case series.
Eder J; Simonitsch-Klupp I; Trautinger F
Eur J Dermatol; 2013; 23(5):658-62. PubMed ID: 24135559
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S
BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571
[TBL] [Abstract][Full Text] [Related]
8. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
Pond GR; Di Lorenzo G; Necchi A; Eigl BJ; Kolinsky MP; Chacko RT; Dorff TB; Harshman LC; Milowsky MI; Lee RJ; Galsky MD; Federico P; Bolger G; DeShazo M; Mehta A; Goyal J; Sonpavde G
Urol Oncol; 2014 May; 32(4):501-8. PubMed ID: 24332646
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma.
Foote MC; McGrath M; Guminski A; Hughes BGM; Meakin J; Thomson D; Zarate D; Simpson F; Porceddu SV
Ann Oncol; 2014 Oct; 25(10):2047-2052. PubMed ID: 25091317
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study.
Sharma P; Djajadiningrat R; Zargar-Shoshtari K; Catanzaro M; Zhu Y; Nicolai N; Horenblas S; Spiess PE
Urol Oncol; 2015 Nov; 33(11):496.e17-23. PubMed ID: 26072110
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
El Zarif T; Nassar AH; Pond GR; Zhuang TZ; Master V; Nazha B; Niglio S; Simon N; Hahn AW; Pettaway CA; Tu SM; Abdel-Wahab N; Velev M; Flippot R; Buti S; Maruzzo M; Mittra A; Gheeya J; Yang Y; Rodriguez PA; Castellano D; de Velasco G; Roviello G; Antonuzzo L; McKay RR; Vincenzi B; Cortellini A; Hui G; Drakaki A; Glover M; Khaki AR; El-Am E; Adra N; Mouhieddine TH; Patel V; Piedra A; Gernone A; Davis NB; Matthews H; Harrison MR; Kanesvaran R; Giudice GC; Barata P; Farolfi A; Lee JL; Milowsky MI; Stahlfeld C; Appleman L; Kim JW; Freeman D; Choueiri TK; Spiess PE; Necchi A; Apolo AB; Sonpavde GP
J Natl Cancer Inst; 2023 Dec; 115(12):1605-1615. PubMed ID: 37563779
[TBL] [Abstract][Full Text] [Related]
12. Treatment for Metastatic Penile Cancer After First-line Chemotherapy Failure: Analysis of Response and Survival Outcomes.
Wang J; Pettaway CA; Pagliaro LC
Urology; 2015 May; 85(5):1104-1110. PubMed ID: 25819619
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis.
Carthon BC; Ng CS; Pettaway CA; Pagliaro LC
BJU Int; 2014 Jun; 113(6):871-7. PubMed ID: 24053151
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer.
Djajadiningrat RS; Bergman AM; van Werkhoven E; Vegt E; Horenblas S
Clin Genitourin Cancer; 2015 Feb; 13(1):44-9. PubMed ID: 25009098
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases.
Brown A; Ma Y; Danenberg K; Schuckman AK; Pinski JK; Pagliaro LC; Quinn DI; Dorff TB
Urology; 2014 Jan; 83(1):159-65. PubMed ID: 24238569
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
Necchi A; Eigl BJ; Yang ES; Bae S; Chandrashekar D; Chen D; Naik G; Mehta A; Giannatempo P; Colecchia M; Gordetsky J; Wei S; Cooper T; Varambally S; Sonpavde G
Eur Urol Focus; 2018 Sep; 4(5):733-736. PubMed ID: 28753783
[TBL] [Abstract][Full Text] [Related]
18. A case of penile squamous cell carcinoma treated with a combination of antiepidermal growth factor receptor antibody and chemotherapy.
Men HT; Gou HF; Qiu M; He JP; Cheng K; Chen Y; Ge J; Liu JY
Anticancer Drugs; 2014 Jan; 25(1):123-5. PubMed ID: 24263192
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study.
Di Lorenzo G; Federico P; Buonerba C; Longo N; Cartenì G; Autorino R; Perdonà S; Ferro M; Rescigno P; D'Aniello C; Matano E; Altieri V; Palmieri G; Imbimbo C; De Placido S; Mirone V
Eur Urol; 2011 Dec; 60(6):1280-4. PubMed ID: 21871710
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Peeters M; Price TJ; Cervantes A; Sobrero AF; Ducreux M; Hotko Y; André T; Chan E; Lordick F; Punt CJ; Strickland AH; Wilson G; Ciuleanu TE; Roman L; Van Cutsem E; Tzekova V; Collins S; Oliner KS; Rong A; Gansert J
J Clin Oncol; 2010 Nov; 28(31):4706-13. PubMed ID: 20921462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
